Enriched HLA-DQ3 phenotype and decreased class I major histocompatibility complex antigen expression in recurrent respiratory papillomatosis
- PMID: 7496977
- PMCID: PMC368263
- DOI: 10.1128/cdli.1.3.357-360.1994
Enriched HLA-DQ3 phenotype and decreased class I major histocompatibility complex antigen expression in recurrent respiratory papillomatosis
Abstract
Respiratory papillomas, caused by human papillomaviruses, are benign tumors that recur following removal. We evaluated immune function and major histocompatibility complex (MHC) phenotype and expression in these patients. MHC-independent immune function appeared normal. The frequency of peripheral blood MHC class II phenotypes was highly enriched for DQ3 and DR11, one split of DR5. Class I MHC antigen expression on papilloma tissue was markedly reduced. Together, these phenomena may facilitate papillomavirus evasion of the cellular immune response.
Similar articles
-
HLA class II antigen expression in human papillomavirus-associated cervical cancer.Cancer Res. 1992 Jul 15;52(14):4009-16. Cancer Res. 1992. PMID: 1377602
-
Significance of the expression of major histocompatibility complex class II antigen, HLA-DR and -DQ, with recurrence of papillary thyroid cancer.Int J Cancer. 2008 Feb 15;122(4):785-90. doi: 10.1002/ijc.23167. Int J Cancer. 2008. PMID: 17957790
-
Immunocompetency in children with recurrent respiratory papillomatosis: prospective study.Ann Otol Rhinol Laryngol. 2007 Mar;116(3):169-71. doi: 10.1177/000348940711600302. Ann Otol Rhinol Laryngol. 2007. PMID: 17419519
-
Pathogenesis and treatment of juvenile onset recurrent respiratory papillomatosis.Otolaryngol Clin North Am. 2000 Feb;33(1):187-207. doi: 10.1016/s0030-6665(05)70215-2. Otolaryngol Clin North Am. 2000. PMID: 10637352 Review.
-
Is tumor expression of the major histocompatibility complex antigen required for T cell immune surveillance?Arch Immunol Ther Exp (Warsz). 2001;49 Suppl 2:S61-4. Arch Immunol Ther Exp (Warsz). 2001. PMID: 11665749 Review.
Cited by
-
Immune Dysregulation in Patients Persistently Infected with Human Papillomaviruses 6 and 11.J Clin Med. 2015 Mar;4(3):375-88. doi: 10.3390/jcm4030375. J Clin Med. 2015. PMID: 26023354 Free PMC article.
-
Immunological tolerance of low-risk HPV in recurrent respiratory papillomatosis.Clin Exp Immunol. 2020 Feb;199(2):131-142. doi: 10.1111/cei.13387. Epub 2019 Oct 31. Clin Exp Immunol. 2020. PMID: 31628850 Free PMC article. Review.
-
Trace Elements Levels in Serum of Patients with Recurrent Respiratory Papillomatosis.Indian J Otolaryngol Head Neck Surg. 2022 Dec;74(Suppl 3):5037-5043. doi: 10.1007/s12070-021-02676-9. Epub 2021 Jun 11. Indian J Otolaryngol Head Neck Surg. 2022. PMID: 36742793 Free PMC article.
-
Papillomavirus-specific CD4+ T cells exhibit reduced STAT-5 signaling and altered cytokine profiles in patients with recurrent respiratory papillomatosis.J Immunol. 2011 Jun 1;186(11):6633-40. doi: 10.4049/jimmunol.1004181. Epub 2011 Apr 29. J Immunol. 2011. PMID: 21531896 Free PMC article.
-
A review of the risk factors associated with juvenile-onset recurrent respiratory papillomatosis: genetic, immune and clinical aspects.World J Pediatr. 2022 Feb;18(2):75-82. doi: 10.1007/s12519-021-00496-z. Epub 2022 Jan 24. World J Pediatr. 2022. PMID: 35072893 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials